121 related articles for article (PubMed ID: 37581220)
21. Convergent Alterations of a Protein Hub Produce Divergent Effects within a Binding Site.
Imran A; Moyer BS; Kalina D; Duncan TM; Moody KJ; Wolfe AJ; Cosgrove MS; Movileanu L
ACS Chem Biol; 2022 Jun; 17(6):1586-1597. PubMed ID: 35613319
[TBL] [Abstract][Full Text] [Related]
22. MLL1/WDR5 complex in leukemogenesis and epigenetic regulation.
Wu M; Shu HB
Chin J Cancer; 2011 Apr; 30(4):240-6. PubMed ID: 21439245
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the H3K4 methyltransferase MLL1/WDR5 complex attenuates renal senescence in ischemia reperfusion mice by reduction of p16
Shimoda H; Doi S; Nakashima A; Sasaki K; Doi T; Masaki T
Kidney Int; 2019 Nov; 96(5):1162-1175. PubMed ID: 31570196
[TBL] [Abstract][Full Text] [Related]
24. Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases.
Dharmarajan V; Lee JH; Patel A; Skalnik DG; Cosgrove MS
J Biol Chem; 2012 Aug; 287(33):27275-89. PubMed ID: 22665483
[TBL] [Abstract][Full Text] [Related]
25. TWIST1-WDR5-
Malek R; Gajula RP; Williams RD; Nghiem B; Simons BW; Nugent K; Wang H; Taparra K; Lemtiri-Chlieh G; Yoon AR; True L; An SS; DeWeese TL; Ross AE; Schaeffer EM; Pienta KJ; Hurley PJ; Morrissey C; Tran PT
Cancer Res; 2017 Jun; 77(12):3181-3193. PubMed ID: 28484075
[TBL] [Abstract][Full Text] [Related]
26. The plasticity of WDR5 peptide-binding cleft enables the binding of the SET1 family of histone methyltransferases.
Zhang P; Lee H; Brunzelle JS; Couture JF
Nucleic Acids Res; 2012 May; 40(9):4237-46. PubMed ID: 22266653
[TBL] [Abstract][Full Text] [Related]
27. Disentangling the recognition complexity of a protein hub using a nanopore.
Mayse LA; Imran A; Larimi MG; Cosgrove MS; Wolfe AJ; Movileanu L
Nat Commun; 2022 Feb; 13(1):978. PubMed ID: 35190547
[TBL] [Abstract][Full Text] [Related]
28. Overlapping characteristics of weak interactions of two transcriptional regulators with WDR5.
Ahmad M; Imran A; Movileanu L
Int J Biol Macromol; 2024 Feb; 258(Pt 2):128969. PubMed ID: 38158065
[TBL] [Abstract][Full Text] [Related]
29. Discovery of Potent Small-Molecule Inhibitors of WDR5-MYC Interaction.
Ding J; Li G; Liu H; Liu L; Lin Y; Gao J; Zhou G; Shen L; Zhao M; Yu Y; Guo W; Hommel U; Ottl J; Blank J; Aubin N; Wei Y; He H; Sage DR; Atadja PW; Li E; Jain RK; Tallarico JA; Canham SM; Chiang YL; Wang H
ACS Chem Biol; 2023 Jan; 18(1):34-40. PubMed ID: 36594833
[TBL] [Abstract][Full Text] [Related]
30. The SCF-FBXW7 E3 ubiquitin ligase triggers degradation of histone 3 lysine 4 methyltransferase complex component WDR5 to prevent mitotic slippage.
Hänle-Kreidler S; Richter KT; Hoffmann I
J Biol Chem; 2022 Dec; 298(12):102703. PubMed ID: 36395886
[TBL] [Abstract][Full Text] [Related]
31. The role of WDR5 in silencing human fetal globin gene expression.
Xu Z; He Y; Ju J; Rank G; Cerruti L; Ma C; Simpson RJ; Moritz RL; Jane SM; Zhao Q
Haematologica; 2012 Nov; 97(11):1632-40. PubMed ID: 22689669
[TBL] [Abstract][Full Text] [Related]
32. WDR5 Stabilizes Actin Architecture to Promote Multiciliated Cell Formation.
Kulkarni SS; Griffin JN; Date PP; Liem KF; Khokha MK
Dev Cell; 2018 Sep; 46(5):595-610.e3. PubMed ID: 30205038
[TBL] [Abstract][Full Text] [Related]
33. LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kγ promoter.
Ni H; Chai P; Yu J; Xing Y; Wang S; Fan J; Ge S; Wang Y; Jia R; Fan X
Cell Death Dis; 2020 May; 11(5):306. PubMed ID: 32366932
[TBL] [Abstract][Full Text] [Related]
34. Structure-based design and synthesis of small molecular inhibitors disturbing the interaction of MLL1-WDR5.
Li DD; Chen WL; Xu XL; Jiang F; Wang L; Xie YY; Zhang XJ; Guo XK; You QD; Sun HP
Eur J Med Chem; 2016 Aug; 118():1-8. PubMed ID: 27116709
[TBL] [Abstract][Full Text] [Related]
35. Human WDR5 promotes breast cancer growth and metastasis via KMT2-independent translation regulation.
Cai WL; Chen JF; Chen H; Wingrove E; Kurley SJ; Chan LH; Zhang M; Arnal-Estape A; Zhao M; Balabaki A; Li W; Yu X; Krop ED; Dou Y; Liu Y; Jin J; Westbrook TF; Nguyen DX; Yan Q
Elife; 2022 Aug; 11():. PubMed ID: 36043466
[TBL] [Abstract][Full Text] [Related]
36. Phage-Display Based Discovery and Characterization of Peptide Ligands against WDR5.
Cao J; Fan T; Li Y; Du Z; Chen L; Wang Y; Wang X; Shen J; Huang X; Xiong B; Cao D
Molecules; 2021 Feb; 26(5):. PubMed ID: 33668971
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the binding of mixed lineage leukemia 1 (MLL1) and histone 3 peptides to WD repeat domain 5 (WDR5) for the design of inhibitors of the MLL1-WDR5 interaction.
Karatas H; Townsend EC; Bernard D; Dou Y; Wang S
J Med Chem; 2010 Jul; 53(14):5179-85. PubMed ID: 20575550
[TBL] [Abstract][Full Text] [Related]
38. The long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migration.
Cheng Y; Jutooru I; Chadalapaka G; Corton JC; Safe S
Oncotarget; 2015 May; 6(13):10840-52. PubMed ID: 25912306
[TBL] [Abstract][Full Text] [Related]
39. A role for WDR5 in integrating threonine 11 phosphorylation to lysine 4 methylation on histone H3 during androgen signaling and in prostate cancer.
Kim JY; Banerjee T; Vinckevicius A; Luo Q; Parker JB; Baker MR; Radhakrishnan I; Wei JJ; Barish GD; Chakravarti D
Mol Cell; 2014 May; 54(4):613-25. PubMed ID: 24793694
[TBL] [Abstract][Full Text] [Related]
40. HBx Protein Contributes to Liver Carcinogenesis by H3K4me3 Modification Through Stabilizing WD Repeat Domain 5 Protein.
Gao W; Jia Z; Tian Y; Yang P; Sun H; Wang C; Ding Y; Zhang M; Zhang Y; Yang D; Tian Z; Zhou J; Ruan Z; Wu Y; Ni B
Hepatology; 2020 May; 71(5):1678-1695. PubMed ID: 31544250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]